Piotr Maciejak

Piotr Maciejak

Auto-generated profile, based on publicly available information

Piotr Maciejak

Department of Neurochemistry, Institute of Psychiatry and Neurology, Sobieskiego 9, PL 02-957 Warszawa, Poland

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MPMałgorzata Pietraszek
Małgorzata Pietraszek
ISIlya Sukhanov
Ilya Sukhanov
PMPiotr Maciejak
Piotr Maciejak
JSJanusz Szyndler
Janusz Szyndler
AGAndreas Gravius
Andreas Gravius
WDWojciech Danysz
Wojciech Danysz

1 November 2006 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
ASA Skorzewska
A Skorzewska
ABA Bidzinski
A Bidzinski
MLMałgorzata Lehner
Małgorzata Lehner
DTD Turzynska
D Turzynska
AWAleksandra Wisłowska-Stanek
Aleksandra Wisłowska-Stanek
APA Plaznik
A Plaznik

1 October 2009 in Epilepsy & Behavior
Verified
Journal Article
Closed access
JSJanusz Szyndler
Janusz Szyndler
PMPiotr Maciejak
Piotr Maciejak
DTDanuta Turzyńska
Danuta Turzyńska
ASAlicja Sobolewska
Alicja Sobolewska
ETEwa Taracha
Ewa Taracha
APAdam Płaźnik
Adam Płaźnik

1 September 2013 in Behavioural Brain Research
Verified
Journal Article
Closed access
AWAleksandra Wisłowska-Stanek
Aleksandra Wisłowska-Stanek
MLMałgorzata Lehner
Małgorzata Lehner
ASAnna Skórzewska
Anna Skórzewska
PKPaweł Krząścik
Paweł Krząścik
PMPiotr Maciejak
Piotr Maciejak
APAdam Płaźnik
Adam Płaźnik


1 May 2018 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Closed access
NCNatalia Chmielewska
Natalia Chmielewska
JSJanusz Szyndler
Janusz Szyndler
KMKarolina Makowska
Karolina Makowska
DWDawid Wojtyna
Dawid Wojtyna
PMPiotr Maciejak
Piotr Maciejak
APAdam Płaźnik
Adam Płaźnik
The role of blood brain barrier (BBB) is to preserve a precisely regulated environment for proper neuronal signaling. In many of the central nervous system (CNS) pathologies, the function of BBB is altered. Thus, there is a necessity to evaluate a fast, noninvasive and reliable method for monitoring of BBB condition. It seems that revealing the peripheral diagnostic biomarker whose release pattern (concentration, dynamics) will be correlated with clinical symptoms of neurological disorders offers significant hope. It could help with faster diagnosis and efficient treatment monitoring. In this review we summarize the recent data concerning exploration of potential new serum biomarkers appearing in the peripheral circulation following BBB disintegration, with an emphasis on epilepsy, traumatic brain injury (TBI) and stroke. We consider the application of well-known proteins (S100β and GFAP) as serum indicators in the light of recently obtained results. Furthermore, the utility of molecules like MMP-9, UCHL-1, neurofilaments, BDNF, and miRNA, which are newly recognized as a potential serum biomarkers, will also be discussed.